# Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

> **NCT03711890** · NA · SUSPENDED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 75 (estimated)

## Conditions studied

- Pancreatic Carcinoma
- Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type

## Interventions

- **PROCEDURE:** Optical Coherence Tomography
- **PROCEDURE:** Therapeutic Conventional Surgery
- **DIAGNOSTIC_TEST:** Laboratory Evaluation

## Key facts

- **NCT ID:** NCT03711890
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-03-26
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 75 (ESTIMATED)
- **Why stopped:** PI decision
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03711890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03711890, "Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03711890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*